Several studies have indicated that higher levels of phospho-tau in AD brain are associated with apoE4 than with apoE3 or apoE2 [42], correlating with the in vitro effects of these isoforms on GSK-3β and CDK5 inhibition (and not with their effects on ERK activation). This evidence concerns the gene APOE and Alzheimer disease.